🇺🇸 FDA
Patent

US 9289451

Methods and compositions for targeted cleavage and recombination

granted A61KA61K2035/124A61K35/12

Quick answer

US patent 9289451 (Methods and compositions for targeted cleavage and recombination) held by Sangamo Biosciences, Inc. expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2035/124, A61K35/12